Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

The Contribution of the Thymus to Autoimmune Phenotypes in GvHD and Colitis

Karlie R. Sharma, PhD, Sarah E Bryant, BS, Sherry Koontz, Harry L. Malech, MD, Elizabeth M. Kang, MD

Blood (2016) 128 (22): 3347.

https://doi.org/10.1182/blood.V128.22.3347.3347

Published: 2016

Journal Articles

Graft Versus Host Disease (GvHD) Is Attenuated By Administration of Pregnancy Specific Glycoproteins through Induction of Immune Tolerance

Karlie R. Sharma, PhD, Shemona Rattila, Patricia Kiesler, PhD, Angela Ballesteros, PhD, Jian Luo, PhD, Sherry Koontz, James Warren, MS, Harry L. Malech, MD, Gabriela Dveksler, PhD, Elizabeth M. Kang, MD

Blood (2015) 126 (23): 4278.

https://doi.org/10.1182/blood.V126.23.4278.4278

Published: 2015

Journal Articles

Allogeneic Transplantation for P40 CGD Is Curative of Inflammatory Disease

Elizabeth M. Kang, MD, Nicola A. Wright, MD FRCPC, Katherine Nicholls, MBBS, FRACP, FRCPA, Dianne Hilligoss, RN, MSN, CRNP, Corin Kelly, RN, Douglas B. Kuhns, PhD, Harry L. Malech, MD

Blood (2015) 126 (23): 5515.

https://doi.org/10.1182/blood.V126.23.5515.5515

Published: 2015

Journal Articles

The Use Of a Novel Nonmyeloablative Conditioning Regimen and Sirolimus For GvHD Prophylaxis To Transplant Patients With Chronic Granulomatous Disease

Elizabeth M. Kang, MD, Harry Malech, MD, Dianne Hilligoss, Martha Marquesen, Corin Kelly, Mark Parta, MD

Blood (2013) 122 (21): 2157.

https://doi.org/10.1182/blood.V122.21.2157.2157

Published: 2013

Journal Articles

A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia

Sabrina Martyr, MD, Arun Balakumuran, MD, PhD, Aldemar Montero, MD, Cynthia E. Dunbar, MD, Elizabeth M. Kang, MD, Phillip Scheinberg, MD, Barbara Weinstein, RN, Xin Tian, Ph.D., Neal S. Young, MD, Adrian Wiestner, MD, PhD

Blood (2013) 122 (21): 2479.

https://doi.org/10.1182/blood.V122.21.2479.2479

Published: 2013

Journal Articles

Adenosine A 2A Receptor Agonist Mediated Prevention of Graft-Versus Host Disease In the Mouse Is Associated with An Increase of T-Regulatory Cells In Target Organs.

Kyu Lee Han, PhD, Sherry Walker, Harry L. Malech, MD, Elizabeth M. Kang, MD

Blood (2010) 116 (21): 3744.

https://doi.org/10.1182/blood.V116.21.3744.3744

Published: 2010

Journal Articles

Successful Control of Preexistent Active Infection by Granulocyte Transfusions During Conditioning Induced Cytopenia In Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Stem Cell Transplant

P. Dayand Borge, Jr., MD, Narda Theobald, MA, Rosamma DeCastro, NP, Harry L. Malech, MD, Susan Leitman, MD, Elizabeth M. Kang, MD

Blood (2010) 116 (21): 1329.

https://doi.org/10.1182/blood.V116.21.1329.1329

Published: 2010

Journal Articles

Activation of the Adenosine A 2A Receptor Promotes the Development of Donor-Derived T Regulatory Cells in a Graft-Versus Host Disease Mouse Model.

Kyu Lee Han, PhD, Cattlena M. Changpriroa, Harry L. Malech, MD, Elizabeth M. Kang, MD

Blood (2009) 114 (22): 1339.

https://doi.org/10.1182/blood.V114.22.1339.1339

Published: 2009

Journal Articles

Treatment of Infections in Patients with X-Linked Chronic Granulomatous Disease (XCGD) with Gene Therapy.

Elizabeth M. Kang, MD, Gilda Linton, Narda Theobald, Sandra Anaya O’Brien, RN, Dianne Hilligoss, CNP, Harry L. Malech, MD

Blood (2007) 110 (11): 504.

https://doi.org/10.1182/blood.V110.11.504.504

Published: 2007

Journal Articles

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Matthew M. Hsieh, MD, Elizabeth M. Kang, MD, Beth Link, Maria Berg, Richard W. Childs, MD, Roger Kurlander, MD, Jonathan Powell, MD PhD, Griffin P. Rodgers, MD, John F. Tisdale, MD

Blood (2006) 108 (11): 2994.

https://doi.org/10.1182/blood.V108.11.2994.2994

Published: 2006

Journal Articles

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Elizabeth M. Kang, MD, Matthew Hsieh, MD, Jonathan D. Powell, MD/PhD, Beth Link, RN, Theresa Donohue, PA, Gregory Kato, MD, Robert Machado, MD, Mark Gladwin, MD, Griffin Rodgers, MD, John F. Tisdale, MD

Blood (2005) 106 (11): 5429.

https://doi.org/10.1182/blood.V106.11.5429.5429

Published: 2005

NARROW

The Contribution of the Thymus to Autoimmune Phenotypes in GvHD and Colitis

Graft Versus Host Disease (GvHD) Is Attenuated By Administration of Pregnancy Specific Glycoproteins through Induction of Immune Tolerance

Allogeneic Transplantation for P40 CGD Is Curative of Inflammatory Disease

The Use Of a Novel Nonmyeloablative Conditioning Regimen and Sirolimus For GvHD Prophylaxis To Transplant Patients With Chronic Granulomatous Disease

A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia

Adenosine A 2A Receptor Agonist Mediated Prevention of Graft-Versus Host Disease In the Mouse Is Associated with An Increase of T-Regulatory Cells In Target Organs.

Successful Control of Preexistent Active Infection by Granulocyte Transfusions During Conditioning Induced Cytopenia In Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Stem Cell Transplant

Activation of the Adenosine A 2A Receptor Promotes the Development of Donor-Derived T Regulatory Cells in a Graft-Versus Host Disease Mouse Model.

Treatment of Infections in Patients with X-Linked Chronic Granulomatous Disease (XCGD) with Gene Therapy.

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

A Novel Allogeneic Transplant Conditioning Regimen Designed for Tolerance Induction in Patients with Severe Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only